"The main objective of this pharmacological research is to identify potential new therapeutic uses for phytocannabinoids, some of which can already be prescribed by doctors to reduce the spasticity and pain of multiple sclerosis"

"My research group is currently focusing on the greatly understudied pharmacology of some of the many unique and fascinating compounds called phytocannabinoids that are produced by cannabis. We are investigating the pharmacology both of synthetic cannabinoids and of endocannabinoids – these are chemicals produced naturally by our own tissues to reduce the severity or unwanted effects of MS"

‘The main objective of this pharmacological research is to identify potential new therapeutic uses for phytocannabinoids, some of which can already be prescribed by doctors to reduce cancer pain or the spasticity and pain of multiple sclerosis.
Click here to read more